Additional file 2 of Feasibility and outcome of reproducible clinical interpretation of high-dimensional molecular data: a comparison of two molecular tumor boards

Additional file 2: Table S1. Reports all gene names and corresponding number of alterations, including SNV, gene expression outliers, indels and gene fusions that were identified in the cohort. Table S2. Lists the genetic alterations that were identified as predictive biomarkers and corresponding treatment options per patient by Heidelberg (HD) and Berlin (BLN) MTBs. Results from a second sequencing for the same patient are indicated by a comma. Table S3. Provides information on treatment options and respective biomarkers for the analyzed cohort. Results from a second sequencing for the same patient are indicated by a comma.

附加文件2：表S1。该表汇总了本研究队列中鉴定得到的全部基因名称及其对应的变异计数，涵盖单核苷酸变异（Single Nucleotide Variant, SNV）、基因表达异常值、插入缺失变异（Insertions and Deletions, indels）与基因融合事件。表S2：列出了由海德堡（HD）与柏林（BLN）分子肿瘤委员会（Molecular Tumor Boards, MTBs）鉴定为预测性生物标志物的基因变异，以及每位患者对应的治疗方案。同一患者的二次测序结果以逗号标注。表S3：提供了本分析队列对应的治疗方案及其相应生物标志物的相关信息。同一患者的二次测序结果以逗号标注。